Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 8 | $948,124 |
| Sells | 28 | $18,740,319 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 22 Nov 2024 16:52 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Director | 21 Nov 2024 | Sale | 24,246 | 139.67 | 3,386,439 | D |
| 12 Sep 2024 11:35 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Director | 10 Sep 2024 | Sale | 604 | 146.67 | 88,589 | D |
| 12 Sep 2024 11:35 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Director | 10 Sep 2024 | Sale | 10,723 | 145.95 | 1,565,022 | D |
| 12 Sep 2024 11:35 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Director | 10 Sep 2024 | Sale | 9,369 | 144.88 | 1,357,381 | D |
| 12 Sep 2024 11:35 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Director | 10 Sep 2024 | Sale | 1,495 | 143.77 | 214,936 | D |
| 05 Aug 2024 21:56 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 02 Aug 2024 | Sale | 6,973 | 159.36 | 1,111,217 | D |
| 05 Aug 2024 21:56 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 02 Aug 2024 | Sale | 175 | 158.85 | 27,799 | D |
| 01 Aug 2024 20:47 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 01 Aug 2024 | Sale | 4,465 | 165.67 | 739,717 | D |
| 14 Jun 2024 18:07 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 14 Jun 2024 | Purchase | 915 | 124.54 | 113,954 | D |
| 14 Jun 2024 18:07 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 14 Jun 2024 | Purchase | 700 | 125.46 | 87,822 | D |
| 14 Jun 2024 17:42 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | 14 Jun 2024 | Purchase | 1,200 | 125.45 | 150,540 | D |
| 14 Jun 2024 17:41 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 14 Jun 2024 | Purchase | 2,000 | 124.08 | 248,160 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 969 | 171.03 | 165,728 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 3,925 | 170.04 | 667,407 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 2,963 | 169.27 | 501,547 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 3,933 | 168.33 | 662,042 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 4,008 | 167.05 | 669,536 | D |
| 22 May 2024 17:14 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 21 May 2024 | Sale | 4,274 | 166.36 | 711,023 | D |
| 12 Mar 2024 20:24 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 11 Mar 2024 | Sale | 3,517 | 193.73 | 681,348 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 156 | 202.55 | 31,598 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 806 | 201.75 | 162,610 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,305 | 200.56 | 261,731 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,822 | 199.53 | 363,544 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,347 | 198.55 | 267,447 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 1,666 | 197.39 | 328,852 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 6,228 | 196.32 | 1,222,681 | D |
| 11 Mar 2024 19:43 | RGEN | REPLIGEN CORP | HUNT ANTHONY | Chief Executive Officer | 08 Mar 2024 | Sale | 3,377 | 195.49 | 660,170 | D |
| 28 Feb 2024 21:56 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | 27 Feb 2024 | Sale | 1,000 | 193.35 | 193,350 | D |
| 26 Feb 2024 20:38 | RGEN | REPLIGEN CORP | BYLUND JAMES | Chief Operating Officer | 23 Feb 2024 | Sale | 4,373 | 198.08 | 866,204 | D |
| 13 Nov 2023 17:10 | RGEN | REPLIGEN CORP | GEBSKI CHRISTINE | See Remarks | 10 Nov 2023 | Sale | 3,788 | 147.13 | 557,328 | D |
| 30 Aug 2023 16:06 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | 29 Aug 2023 | Sale | 850 | 171.38 | 145,673 | D |
| 08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 08 May 2023 | Purchase | 500 | 156.18 | 78,090 | D |
| 08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 05 May 2023 | Purchase | 500 | 159.19 | 79,595 | D |
| 08 May 2023 21:15 | RGEN | REPLIGEN CORP | MADAUS MARTIN D | Director | 04 May 2023 | Purchase | 500 | 161.15 | 80,575 | D |
| 17 Feb 2023 16:56 | RGEN | REPLIGEN CORP | SNODGRES JON | Chief Financial Officer | 16 Feb 2023 | Sale | 5,647 | 200 | 1,129,400 | D |
| 15 Dec 2022 06:55 | RGEN | REPLIGEN CORP | EGLINTON MANNER CARRIE | Director | 16 Mar 2022 | Purchase | 625 | 175.02 | 109,388 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)